Journals / Selçuk Tıp Dergisi / 2021 / Cilt: 37 - Sayı: 2

Hospital-Acquired Escherichia coli Infection including OXA- 48 Gene: Case Report

OXA-48 Genine Sahip Hastane Kökenli Escherichia coli Enfeksiyonu: Olgu Bildirimi

Pages
176–179
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is thoughtThat it would be beneficial to report these cases in order to report the isolation of E. coli isolates with OXA-48 resistance gene and to prevent the spread of this resistance ge ne in these microorganisms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since it is the most abundant bacteria in the flora, resistance to E. coli, especially the development of carbapenemase-producing strains, is one of the undesired situations.
📊
Key Findings & Data:In our hospital, E. coli isolates with OXA-48 resistance gene were isolated from the clinical samples of two patients.
💡
Conclusion & Impact:It is thoughtThat it would be beneficial to report these cases in order to report the isolation of E. coli isolates with OXA-48 resistance gene and to prevent the spread of this resistance ge ne in these microorganisms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Since it is the most abundant bacteria in the flora, resistance to E. coli, especially the development of carbapenemase-producing strains, is one of the undesired situations. In our hospital, E. coli isolates with OXA-48 resistance gene were isolated from the clinical samples of two patients. It is thoughtThat it would be beneficial to report these cases in order to report the isolation of E. coli isolates with OXA-48 resistance gene and to prevent the spread of this resistance ge ne in these microorganisms.

Özet

Florada en çok bulunan bakterilerden olduğundan dolayı E. coli’ye karşı direnç gelişimi, özellikle karbapenemaz üreten suşların gelişimi, istenmeyen durumların başında gelmektedir. Hastanemizde iki hastanın klinik örneklerinden OXA-48 direnç genine sahip E. coli izolatları izole edilmiştir. OXA-48 direnç genine sahip E. coli izolatlarının izole edildiğinin bildirilmesi ve bu direnç geninin bu mikroorganizmalarda yayılmasının engellenmesi konusunda dikkatlerin çekilmesi amacıyla bu vakaların bildirilmesinin faydalı olacağı düşünülmüştür.

🔖

Cite This Article

Dogan, M., Arslan, G. K., Ugrakli, S. (2022). Hospital-Acquired Escherichia coli Infection including OXA- 48 Gene: Case Report. Selçuk Tıp Dergisi, Cilt: 37 - Sayı: 2, 176–179. https://ajindex.com/articles/591770

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Labi AK, Bjerrum S, Enweronu-Laryea CC, et al. High carriage rates of multidrug-resistant Gram-negative bacteria in neonatal intensive care units from Ghana. OFID 2020;7(4):Ofaa-109. Denk A, Tartar A. İdrar kültürlerinden izole edilen toplum kökenli Escherichia coli suşlarında antibiyotik direnci. FÜ Sağ Bil Tıp Derg 2015;29(2):51-5.
  2. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in enterobacteriaceae: Here is the storm! Trends Mol Med 2012;18(5):263-72.
  3. Kutlu HH, Us E, Tekeli A. Bir üniversite hastanesinde 2010-2014 yılları arasında izole edilen enterobacteriaceae türlerinin karbapenemaz genlerinin araştırılması ve moleküler epidemiyolojisinin belirlenmesi. Mikrobiyol Bul 2018;52(1):1- 12. Patel G, Bonomo R. “Stormy waters ahead”: Global emergence of carbapenemases. Front Microbiol 2013;4:48. Nordmann P, Cornaglia G. Carbapenemase-producing enterobacteriaceae: A call for action! Clin Microbiol Infect 2012;18(5):411-2. Carrër A, Poirel L, Yilmaz M, et al. Spread of OXA-48- encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010;54(3):1369-73.
  4. Kahraman EP, Toptan H, Otlu B, et al. Karbapenemaz üreten klebsiella pneumoniae suslarinda blaoxa-48-benzeri genlerin arastirilmasi. Mikrobiyol Bul 2019:134-43.
  5. Papp-Wallace KM, Endimiani A, Taracila MA, et al. Carbapenems: Past, present, and future. Antimicrob Agents Chemother 2011;55(11):4943-60.
  6. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17(10):1791. Güran M. Karbapenemaz enzimleri: Türkiye'deki durum üzerine bir derleme/carbapenemase enzymes: A review on situation at Turkey. Türkiye Klinikleri Jmed Sci 2016;36(2):98. Khajuria A, Praharaj AK, Kumar M, et al. Emergence of escherichia coli, co-producing NDM-1 and OXA-48 carbapenemases, in urinary isolates, at a tertiary care centre at central India. J Clin Diagn Res 2014;8(6):DC01.